Literature DB >> 7304563

Seroepidemiologic studies of acute hemorrhagic conjunctivitis virus (enterovirus type 70) in West Africa. II. Studies with human sera collected in West African countries other than Ghana.

R Kono, K Miyamura, S Yamazaki, A Sasagawa, H Kurahashi, E Tajiri, N Takeda, Y Robin, J Renaudet, K Ishii, N Nakazono, H Sawada, Y Uchida, K Minami.   

Abstract

Human sera were collected in Senegal, Nigeria, Ivory Coast, Dahomey, Liberia, Gabon and Togo during the pre-epidemic period of acute hemorrhagic conjunctivitis (AHC) from 1965 to 1969, and tested for virus neutralizing (VN) antibody to enterovirus type 70 (EV70). Of these, 1109 (91%) were antibody negative (less than equal to 1:4), 116 (9%) neutralized at a dilution of 1:8 or over, and 45 (4%) at dilutions of at least 1:16. The distribution pattern is not significantly different from that of sera collected from Kenya in 1967 or from army recruits in the United States, Argentina, Brazil and Colombia in the 1960s. Sera collected during the post-epidemic period (1970 to 1977) in Senegal, Sierra Leone, Mali, Upper Volta, Chad, Niger and Gabon were also examined; 1573 (68%) were VN antibody negative (less than or equal to 1:4), while 733 (32%) and 433 (19%) had titers of 1:8 or greater and 1:16 or over, respectively. There is a significant difference in distribution between pre- and post-epidemic antibody titers (p less than 0.001), although the incidence of AHC was lower in these countries than in Ghana and Southeast Asia. The prevalence of VN antibodies tends to be lower in the dry, hot inland areas and thus humid coastal monsoonal climates and dense populations seem to favor the spread of AHC.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7304563     DOI: 10.1093/oxfordjournals.aje.a113192

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  3 in total

1.  Evolution of enterovirus 70 in nature: all isolates were recently derived from a common ancestor.

Authors:  K Miyamura; M Tanimura; N Takeda; R Kono; S Yamazaki
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

2.  Molecular evolution of the major capsid protein VP1 of enterovirus 70.

Authors:  N Takeda; M Tanimura; K Miyamura
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

3.  Quantitation of enterovirus 70 antibody by microneutralization test and comparison with standard neutralization, hemagglutination inhibition, and complement fixation tests with different virus strains.

Authors:  J C Hierholzer; P G Bingham; R A Coombs; Y O Stone; M H Hatch
Journal:  J Clin Microbiol       Date:  1984-06       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.